Point Biopharma Global Inc Net Income per Employee (PNT), current and historic results, rankings and more, Quarterly Fundamentals - CSIMarket
CSIMarket Company Name, Ticker, Suppliers, else..
 


• Sales per Employee
• Income per Employee
• Inventory Turnover
• Asset Turnover
• Receivables Turnover
Point Biopharma Global Inc   (NASDAQ: PNT)
 

Point Biopharma Global Inc Net Income per Employee

PNT's Quarterly Results, Trends, Rankings, Statistics
Point Biopharma Global Inc 's Income per employee fell in the third quarter 2023 on a trailing twelve month basis to $ 965,512, but the productivity of Point Biopharma Global Inc 's 100 employees remained above the company average.
The Healthcare sector has seen employees of 12 other companies achieving higher income per employee. While Point Biopharma Global Inc 's total ranking has deteriorated compared to the previous quarter from 81 to 181.


What is Income per Employee Ratio?





Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

PNT Net Income per Employee (Sep 30 2023)
III. Quarter		 (Jun 30 2023)
II. Quarter		 (Mar 31 2023)
I. Quarter		 (Dec 31 2022)
IV. Quarter		 (Sep 30 2022)
III. Quarter
Y / Y Net Income Change - - - - -
Net Income per Employee (TTM) $ 965,512 973,125 981,431 982,932 -791,707
PNT's Total Ranking # 181 # 81 # 89 # 102 # 0
Seq. Net Income Change - - - - -

PNT Company Profile >> Back to PNT Efficiency Comparisons >> Compare PNT Net Income per Employee to its Competitors

PNT Net Income per Employee Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 13
Healthcare Sector # 19
Overall Market # 181

Net Income per Employee Statistics
High Average Low
$ 982,932 $ 85,298 $ -1,018,870
(Dec 31 2022)   (Sep 30 2022)







Companies with similar Income per Employee for 12 month ending Sep 30 2023, within Healthcare Sector Income per Employee Income 12 month ending Sep 30 2023Number of Employees Sep 30 2023
Kaya Holdings Inc   1,574,074.00 $ 3.148  Million 2 
Evofem Biosciences Inc   1,503,931.03 $ 43.614  Million 29 
Atlantic Coastal Acquisition Corp Ii  1,428,647.00 $ 4.286  Million 3 
Biomx Inc  1,328,200.00 $ 26.564  Million 20 
Inhibitor Therapeutics Inc   1,312,685.25 $ 10.501  Million 8 
Opus Genetics Inc   1,026,785.71 $ 28.750  Million 28 
Point Biopharma Global Inc   965,512.40 $ 96.551  Million 100 
Shockwave Medical Inc   963,968.38 $ 243.884  Million 253 
Arcturus Therapeutics Holdings Inc   894,855.86 $ 99.329  Million 111 
Zymeworks Inc   777,420.45 $ 205.239  Million 264 
Orgenesis Inc   773,597.40 $ 59.567  Million 77 
Denali Therapeutics Inc   656,268.39 $ 330.103  Million 503 
United Therapeutics Corporation  642,714.29 $ 899.800  Million 1,400 
Semler Scientific inc   631,548.39 $ 19.578  Million 31 
Halozyme Therapeutics Inc   600,255.32 $ 253.908  Million 423 
Amgen Inc   582,000.00 $ 7,566.000  Million 13,000 
Cdt Equity Inc   581,341.50 $ 2.325  Million 4 
Harmony Biosciences Holdings inc   514,522.18 $ 150.755  Million 293 


Date modified: 2026-06-22T16:30:32+00:00




Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.